greeksoup/ stock research
Stock research / United States / WVE / 13F holders

Wave Life Sciences, Inc. 13F holders

239 funds reported a position in Wave Life Sciences, Inc. in their 13F for the quarter ended 30 June 2026, together 182.6 million shares worth $1.06 billion. Against the quarter before, 46 opened a position, 100 added, 53 trimmed and 39 sold out; together they bought a net 10.8 million shares. The largest holders: Ra Capital Management, L.P., BlackRock, Inc. and GSK plc.

Funds holding239+7 on Q1 2026
Shares they held182.6Mworth $1.06 billion
Net bought on the quarter10.8M sharesabout $62.6 million at the funds' values
Funds buying to selling146 to 92opened or added, to cut or sold
Opened 46Added 100Held 38Trimmed 53Sold out 39
Opened: 46 fundsAdded: 100 fundsHeld: 38 fundsTrimmed: 53 fundsSold out: 39 funds

What each fund did in WVE against its 13F for the quarter before; a change under 0.1% of a holding counts as held

Q3 2024: 162 funds, 120.7 million shares162Q3 2024Q4 2024: 183 funds, 128.7 million shares183Q4 2024Q1 2025: 196 funds, 131.5 million shares196Q1 2025Q2 2025: 176 funds, 139.0 million shares176Q2 2025Q3 2025: 189 funds, 144.5 million shares189Q3 2025Q4 2025: 219 funds, 182.8 million shares219Q4 2025Q1 2026: 232 funds, 172.6 million shares232Q1 2026Q2 2026: 239 funds, 182.6 million shares239Q2 2026

Funds reporting a position in WVE in their 13F, each quarter; hover a bar for the shares they held

Filed so far for the quarter to 30 September 2026

3,241 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 34 reported a position in Wave Life Sciences, Inc.: 4 opened one, 13 added, 12 trimmed and 10 sold out, a net 832,971 shares bought.

FundChange in sharesShares nowStatusFiling
Y-Intercept (Hong Kong) Ltd+772,3821,382,476added13F
Profund Advisors LLC+240,754288,348added13F
Exchange Traded Concepts, LLC-35,79144,641trimmed13F
Caitong International Asset Management Co., Ltd-33,4734,723trimmed13F
FNY Investment Advisers, LLC+30,00030,000new13F
Carolina Wealth Management Inc+20,00052,500added13F
James J. Burns & Company, LLC-14,000100,800trimmed13F
Matisse Capital-10,00035,723trimmed13F
China Universal Asset Management Co., Ltd.+5,33335,954added13F
State of Wyoming-4,5988,223trimmed13F
GF Fund Management Co. Ltd+2,1136,098added13F
Vontobel Holding Ltd.+2,00014,000added13F
IFP Advisors, Inc-1,412749trimmed13F
Mirae Asset Global Investments Co., Ltd.+1,46410,069added13F
Versant Capital Management, Inc+1,2171,371added13F
Signaturefd, LLC+6071,917added13F
Parkside Financial Bank & Trust+499499new13F
Gamma Investing LLC+381857added13F
Oppenheimer & Co. Inc.-35248,770trimmed13F
Financial Consulate, Inc.+322322new13F
Farther Finance Advisors, LLC-3222,148trimmed13F
MassMutual Private Wealth & Trust, FSB-3001,050trimmed13F
Sterling Capital Management LLC+2662,890added13F
SJS Investment Consulting Inc.-22775trimmed13F
ProShare Advisors LLC+20124,575added13F

The largest moves in the name among the funds that have filed, against each fund's previous 13F.

The well-known funds

Of the 44 funds followed here, 8 reported a position in Wave Life Sciences, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 4.9 million shares worth $28.6 million, 0.0% of its reported book. New this quarter: Point72 Asset Management. In the quarter, 5 funds added or opened a position and 2 trimmed or sold out; together they bought a net 3.6 million shares, about $20.7 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
FMR LLC4,922,477$28.6 million0.0%-270,284trimmed30 June 202613F
Geode Capital Management3,869,998$22.5 million0.0%+290,899added30 June 202613F
Two Sigma Investments3,707,686$21.5 million0.0%+1,829,571added30 June 202613F
Millennium Management1,811,282$10.5 million0.0%+839,041added30 June 202613F
Renaissance Technologies1,704,520$9.9 million0.0%+1,107,300added30 June 202613F
Point72 Asset Management1,484,989$8.6 million0.0%+1,484,989new30 June 202613F
Citadel Advisors480,154$2.8 million0.0%-1,722,702trimmed30 June 202613F
Duquesne Family Office173,000$1.0 million0.0%no changeheld30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

The largest holders

FundSharesShare of allValueOf its bookChange in sharesFiling
Ra Capital Management, L.P.26,975,50514.77%$156.7 million1.36%no change13F
BlackRock, Inc.19,202,46110.52%$111.6 million0.00%+5,085,04913F
GSK plc18,245,6919.99%$106.0 million17.60%no change13F
Maverick Capital Ltd10,278,1155.63%$59.7 million0.54%+116,71613F
Driehaus Capital Management LLC5,443,1432.98%$31.6 million0.18%+12,12213F
Primecap Management Co.5,354,6222.93%$31.1 million0.02%+521,67013F
683 Capital Management, LLC4,950,0002.71%$28.8 million2.76%+50,00013F
FMR LLC4,922,4772.70%$28.6 million0.00%-270,28413F
State Street Corp.4,839,3172.65%$28.1 million0.00%+1,165,28413F
Readystate Asset Management LP4,727,1392.59%$27.5 million1.81%new13F
M28 Capital Management LP4,588,2842.51%$26.7 million56.53%no change13F
Geode Capital Management, LLC3,869,9982.12%$22.5 million0.00%+290,89913F
Two Sigma Investments, LP3,707,6862.03%$21.5 million0.02%+1,829,57113F
Algert Global LLC2,817,6151.54%$16.4 million0.19%+1,502,02613F
Qube Research & Technologies Ltd2,776,0001.52%$16.1 million0.02%+2,620,07613F
Squarepoint Ops LLC2,541,4421.39%$14.8 million0.03%+1,079,05213F
Morgan Stanley2,422,7051.33%$14.1 million0.00%+1,061,70413F
Vanguard Portfolio Management LLC2,110,7511.16%$12.3 million0.00%+934,54413F
Pfizer Inc1,875,0001.03%$10.9 million6.42%no change13F
Millennium Management LLC1,811,2820.99%$10.5 million0.01%+839,04113F
Price T Rowe Associates Inc.1,806,4670.99%$10.5 million0.00%-6,898,08313F
D. E. Shaw & Co., Inc.1,772,2280.97%$10.3 million0.01%+1,699,92313F
Vanguard Capital Management LLC1,751,4030.96%$10.2 million0.00%+139,55013F
Schroder Investment Management Group1,746,6430.96%$9.9 million0.01%+305,58413F
Dimensional Fund Advisors LP1,707,8090.94%$9.9 million0.00%new13F
Renaissance Technologies LLC1,704,5200.93%$9.9 million0.01%+1,107,30013F
AQR Capital Management LLC1,648,0450.90%$9.6 million0.00%+1,196,86013F
Goldman Sachs Group Inc.1,622,3420.89%$9.4 million0.00%+238,75213F
Point72 Asset Management, L.P.1,484,9890.81%$8.6 million0.01%new13F
Federated Hermes, Inc.1,466,2340.80%$8.5 million0.01%-3,851,22313F
RTW Investments, LP1,350,0000.74%$7.8 million0.07%no change13F
Northern Trust Corp.1,253,5000.69%$7.3 million0.00%+64,27013F
Charles Schwab Investment Management Inc.1,224,4450.67%$7.1 million0.00%+45,16613F
Emerald Advisers, LLC1,223,9650.67%$7.1 million0.17%-37,21813F
Marshall Wace, LLP999,5330.55%$5.8 million0.01%-790,34913F
Pictet Asset Management Holding SA917,4090.50%$5.3 million0.01%-231,71813F
Vanguard Fiduciary Trust Co.887,6770.49%$5.2 million0.00%+8,84413F
Aberdeen Group plc876,4580.48%$5.1 million0.01%+326,45813F
Emerald Mutual Fund Advisers Trust847,9990.46%$4.9 million0.17%+33,47013F
Baker Bros. Advisors LP822,6380.45%$4.8 million0.02%no change13F
BNP Paribas Financial Markets811,0570.44%$4.7 million0.00%+530,03413F
Capital Fund Management S.a.734,7460.40%$4.3 million0.03%+551,41513F
Sphera Funds Management Ltd638,2720.35%$3.7 million0.53%+90,00013F
JPMorgan Chase & Co.618,1720.34%$3.5 million0.00%-51,99813F
Y-Intercept (Hong Kong) Ltd610,0940.33%$3.5 million0.07%+453,08113F
Susquehanna Portfolio Strategies, LLC608,1940.33%$3.5 million0.06%+412,35413F
Tang Capital Management LLC600,0000.33%$3.5 million0.16%no change13F
Walleye Capital LLC585,4530.32%$3.4 million0.02%+91,94113F
Nuveen, LLC549,2820.30%$3.2 million0.00%-108,43813F
Bank of America Corp.517,0540.28%$3.0 million0.00%+280,29413F
The 50 largest of the 239 funds that reported a position in WVE in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read moreShare of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. WVE changed its CUSIP in the period, and shares a fund reported under the earlier one are counted on today's basis. What is a 13F?

Options the funds reported on WVE

FundOptionShares under the optionsValue of those sharesQuarter endedFiling
Citadel AdvisorsCalls69,900$406,11930 June 202613F
Citadel AdvisorsPuts68,700$399,14730 June 202613F
Point72 Asset ManagementCalls2,800$16,26830 June 202613F
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read moreThey are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
27 October 202613GBlackRock, Inc. and 1 other13.4 million6.8%30 September 2026passive, institutional (13d-1(b))EDGAR
27 October 202613G/ABlackRock, Inc. and 1 other00.0%30 September 2026passive, institutional (13d-1(b))EDGAR
11 August 202613D/ARA Capital Management, L.P. and 3 others34.3 million16.8%7 August 2026Item 4 of the Statement is hereby amended and supplemented as follows: On August 7, 2026, as part of the Redomiciliation, Wave-Delaware, became the ultimate parent company of the Wave Life Sciences group of companies. Pursuant to the SchemeEDGAR
13 May 202613G/AAdage Capital Management, L.P. and 5 others1.0 million0.5%31 March 2026passive, institutional (13d-1(b))EDGAR
6 May 202613G/AFMR LLC and 3 others5.2 million2.8%31 March 2026passive, institutional (13d-1(b))EDGAR
17 April 202613D/ARA Capital Management, L.P. and 3 others34.2 million17.1%15 April 2026Item 4 of the Statement is hereby amended and supplemented as follows: On April 15, 2026, the Issuer into an Implementation Agreement, dated as of April 15, 2026 (the "Implementation Agreement"), with a newly established Delaware corporatioEDGAR
30 March 202613D/ARA Capital Management, L.P. and 3 others34.2 million17.5%26 March 2026EDGAR
12 February 202613G/AAdage Capital Management, L.P. and 5 others9.8 million5.3%31 December 2025passive, institutional (13d-1(b))EDGAR
5 February 202613GFMR LLC and 3 others15.0 million8.5%31 December 2025passive, institutional (13d-1(b))EDGAR
15 December 202513D/ARA Capital Management, L.P. and 3 others25.5 million13.4%11 December 2025EDGAR
13 November 202513D/ARA Capital Management, L.P. and 3 others25.5 million14.6%11 November 2025EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13G

Fails to deliver

Settlement dateShares failedPriceFile
23 September 20261,660$4.35SEC
22 September 20261,660$4.26SEC
21 September 202625,752$4.35SEC
8 September 202616$4.86SEC
1 September 20267,997$4.90SEC
31 August 20261,240$5.04SEC
28 August 202626,539$5.16SEC
27 August 202620,200$5.23SEC
25 August 202619,913$5.12SEC
24 August 202621,852$5.29SEC
21 August 202629,709$5.25SEC
20 August 202662,579$5.42SEC
19 August 202626,712$5.29SEC
18 August 202640,188$5.09SEC
17 August 202664,452$5.41SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 64,452 on 17 August 2026. A fail is an operational fact about settlement, not a position.